Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Immunocytochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- BM4079S - Provider product page
- Provider
- Acris Antibodies GmbH
- Proper citation
- Acris Antibodies GmbH Cat#BM4079S, RRID:AB_1008771
- Product name
- anti p53 (TP53) (16-25)
- Antibody type
- Monoclonal
- Antigen
- Bacterially expressed full-length wild-type p53.
- Reactivity
- Human, Simian
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- BP53-12
- Vial size
- 0.1 mg
- Concentration
- 1.0 mg/ml
Submitted references Epitope analysis of the human p53 tumour suppressor protein.
Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies.
p53 protein alterations in human testicular cancer including pre-invasive intratubular germ-cell neoplasia.
Dolezalová H, Vojtĕsek B, Kovarík J
Folia biologica 1997;43(1):49-51
Folia biologica 1997;43(1):49-51
Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies.
Bártek J, Bártková J, Vojtĕsek B, Stasková Z, Lukás J, Rejthar A, Kovarík J, Midgley CA, Gannon JV, Lane DP
Oncogene 1991 Sep;6(9):1699-703
Oncogene 1991 Sep;6(9):1699-703
p53 protein alterations in human testicular cancer including pre-invasive intratubular germ-cell neoplasia.
Bártková J, Bártek J, Lukás J, Vojtĕsek B, Stasková Z, Rejthar A, Kovarík J, Midgley CA, Lane DP
International journal of cancer. Journal international du cancer 1991 Sep 9;49(2):196-202
International journal of cancer. Journal international du cancer 1991 Sep 9;49(2):196-202
No comments: Submit comment
Supportive validation
- Submitted by
- Acris Antibodies GmbH (provider)
- Main image
- Experimental details
- Confocal Microscopy of Human HeLa cells using BM4079F p53 antibody (BP53-12, FITC). The expression of p53 protein was enhanced by intercalating reagent. Cells were fixed and permeabilized before incubation with the p53-FITC antibody. Photo provided by Dr. Hodny, Inst. of Experimental Medicine, Prague, Czech Republic.